Purpose In our study we explored the need to define a core outcome set for primary frozen shoulder. Methods We investigated the outcomes used by studies included in a systematic review of the management of primary frozen shoulder; surveyed which primary outcome measures health care professionals considered important; and re-examined papers previously obtained for a systematic review of patients' views of interventions for frozen shoulder to investigate their views on outcomes. Results Thirty-one studies investigated the outcomes range of movement (28 studies), pain (22), function and disability (22), adverse events (13), quality of life (7) and other outcomes (5). Many different types of pain and ranges of movement were measured. Function and disability was measured using fifteen instruments, the content of which varied considerably. Function and disability, pain and range of movement (132, 108 and 104 respondents, respectively) were most often cited by health care professionals as the primary outcome measure that should be used. Searches identified one paper that included patients' views. Outcomes of importance to patients were pain at night, general pain, reduced mobility (resulting in modification of activities) and the emotional impact of frozen shoulder. Conclusions We identified a diverse range of outcomes that have been used or are considered to be important. The development of a core outcome set would improve the design and reporting of studies and availability of data for evidence synthesis. Methods used to develop a core outcome set should be robust, transparent and reflect the views of all stakeholders.
Introduction
Numerous systematic reviews have been conducted to determine the most effective treatment pathways for primary frozen shoulder, a potentially painful and debilitating condition that can last for several years. However, limitations in the methodology and reporting of many clinical trials in this area have hindered the development of a robust evidence base to support available treatment choices [1] [2] [3] [4] [5] [6] [7] [8] . When conducting such reviews, the study outcomes assessed determine whether a treatment is considered effective. The chosen outcomes must be relevant to health service users and decision-makers to inform policy and practice. The wide range of outcomes reported in frozen shoulder trials limits the statistical synthesis of data (metaanalysis) in systematic reviews and may increase the likelihood of selective outcome reporting, which can introduce bias. To facilitate clinical decision-making, it is important that study outcomes data can be synthesised and compared across studies. The diverse range of outcome measures reflects the lack of consensus regarding the selection of outcomes chosen and reported by the primary studies for frozen shoulder [2, 7] .
There has been a growing recognition for the need to develop a standardised set of outcome measures in trials for treatments of a specific condition, which has been termed a ''core outcome set'' [9] . This involves the identification of relevant and important outcome measures to be used routinely by researchers in particular clinical areas. Additional outcome measures can be added to these within the context of each individual trial; however, it would be important to present the findings for both the core set and the additional measures [9] . The development of core outcome sets has the potential to reduce heterogeneity between trials, lead to research that is more likely to have measured relevant outcomes, and enhance the value of evidence synthesis by reducing the risk of outcome reporting bias and ensuring that all trials contribute usable information [10] .
There have been reviews published about the quality of shoulder disability questionnaires such as those by Bot et al. [11] and Paul et al. [12] . These reviews, however, have focused on the psychometric properties of questionnaires for shoulder problems in general and only for patient self-reported outcome measures. Williamson et al. [13] recently suggested that a review of previous trials can provide evidence that a core outcome set is needed and identify a potential list of outcomes. To our knowledge, there has been no attempt to provide a broad overview of all types of outcomes reported in the studies of frozen shoulder and to explore whether there is consensus in choice of outcomes. The aim of this study was to explore the need for a core outcome set for frozen shoulder. To do this, we have (1) investigated the outcome measures reported in studies of primary frozen shoulder in both primary and secondary care using a recently published systematic review [7] ; (2) considered outcomes of importance to health care professionals [14] ; and (3) explored whether a systematic review of the literature for patients' preferences for treatment elicited patients' views on what outcomes they consider important [7] .
Materials and methods

Choice of outcomes used in studies of primary frozen shoulder
We assessed the outcomes reported by studies included in a systematic review of strategies used in the NHS for the management of primary frozen shoulder [7] . We searched fifteen electronic databases from inception to March 2010, with update searches of MEDLINE and EMBASE to January 2011. There were no limits on language of publication or study design. The systematic review methods are described in detail in the full HTA monograph [7] .
Details of the study populations were extracted from the primary studies (age, % female, stage of condition, study interventions). The mean and standard deviation of the overall age of the participants were extracted when possible. The frequency of outcome measures is reported for the following categories: pain, quality of life, function and disability, range of movement, adverse events and other outcomes. Our choice of outcome categories was informed by knowledge of the clinical course of frozen shoulder, which is well established. Initially, pain predominates, for example, in the profile presented by Boyle-Walker et al. [15] , pain was noticed before any loss of motion by more than 90 % of responders. Stiffness then ensues combining with pain to impair function and contribute to disability, and eventually becoming the predominant symptom. ''Pain predominant'' and ''stiffness predominant'' have recently been recommended as a stage classification system for frozen shoulder [16] , emphasising the perceived importance of these two aspects. Due to the complex relationships between these experiential aspects of frozen shoulder (pain, stiffness, functional impairment and disability), none can serve as proxy for another. Likewise, quality of life would be expected to overlap with measures of function and disability, but to be nonetheless distinct.
Any question that considered the patient experience of pain was included in the pain category. Health-related quality of life outcomes were defined as generic (measuring quality of life across a range of conditions) or condition specific. Instruments that assessed function and/or disability domains were classified as function and disability outcomes. As a wide variety of function and disability instruments were reported in the primary studies, we compared the content of the instruments by investigating whether pain, physical function (i.e. ability to do daily activities and range of motion), emotional functioning, social functioning (including work) and other domains were assessed. Range of movement terminology varied between studies, so a senior physiotherapist with musculoskeletal expertise (LG) grouped together similar measures of range of movement. Adverse events were as defined by the primary study. Any outcomes that did not fall into these categories were categorised as ''other''.
Survey of opinions of health care professionals A survey of health care professionals asked a range of professional groups about current treatment pathways and opinions on priorities for research into treatments for the management of frozen shoulder [14] . The respondents included: general practitioners specialising in musculoskeletal pain and dysfunction (contacted via the Primary Care Rheumatology Society); physiotherapists (via the National Physiotherapy Research Network); and Orthopaedic surgeons with an interest in shoulder conditions (via the British Elbow and Shoulder Society). As part of this survey, the health care professionals recorded which primary outcome they considered important to measure when comparing treatments of the frozen shoulder. This question was an open response item. Responses were coded by two independent authors (SR and LJ) who resolved any disagreement through discussion. The following categories were generated to classify study outcomes: pain, function/ disability, range of movement, quality of life, adverse events, cost-effectiveness and other outcomes. Where responses involved more than one category (e.g. pain and range of movement), both were recorded.
Patients' views on outcomes
In a previous HTA systematic review, we searched three databases (CINAHL, MEDLINE and PsycINFO) from 1980 to 2010 for English-language papers investigating patients' views of interventions for frozen shoulder. The search strategy is described in detail in the HTA monograph [7] . Qualitative studies investigating patients' views or experiences about the treatments that were included in the main review were eligible for inclusion. Expert opinion, letters without data on patient views, editorials and discussion papers were excluded. The process of study selection is reported in the main review. Quality was assessed using a tool developed by Hawker et al. [17] , which scores nine quality items as good, fair, poor or very poor [7] .
The papers obtained for the previous HTA review were re-screened by one reviewer (SR) to investigate whether any additional information was available in these papers regarding patients' views on what are important outcomes to patients.
Results
Choice of outcomes used in the studies of primary frozen shoulder Thirty-two studies were included in the systematic review; 28 RCTs, one non-randomised controlled study, two case series and one cost-utility study (this study was not included in the present analysis). The mean age of participants ranged from 50 to 64 years when reported, the stage of frozen shoulder was often not reported, and when it was reported a range of classifications were used. A wide range of interventions were included (Table 1) . Outcome frequencies were as follows: pain (n = 22), quality of life (n = 7), function and disability (n = 22), range of movement (n = 28), adverse events (n = 13) and other (n = 5). The variability in outcomes reported in the included studies are summarised in Table 1 , adapted from the outcome matrix developed in the recent Outcome-Reporting Bias in Trials (ORBIT) study [18] . The number of outcomes per study ranged from a single outcome measure [19] to all outcome measures (excluding ''other'') [20] . The most common combination of outcomes from 14 studies was pain, function and disability and range of movement.
Pain was commonly reported (22 studies), but there was little consensus, with pain category and scale calibration varying across studies ( Table 2) .
A generic health-related quality of life measure was used in seven studies ( Table 2 ). The Medical Outcomes Study Short Form SF-36 was used most often (five studies). One study appeared to use the Health Assessment Questionnaire Disability Index which is a generic disability questionnaire designed for patients with rheumatic diseases [21] . Another study used the Problem Elicitation Technique (PET), which is a non-standardised patient preference disability questionnaire where the patient nominates problems relevant to them and assesses the magnitude [20] .
The instruments used to assess function and/or disability are presented in Table 3 . These were included in 22 studies, ten of which used more than one instrument. Fifteen different instruments were used, and the content of the instruments varied considerably in terms of the domains assessed, with emotional and social domains the least frequently assessed. The most commonly used instrument was the Shoulder Pain and Disability Index (SPADI) total score in seven studies (which assessed pain and physical domains).
Twenty-eight studies reported at least one range of movement. Nineteen different categories of range of movement were reported ( Table 2 ). The most commonly reported range of movement was active external rotation (20 studies).
Thirteen studies reported that adverse events were assessed. Of these, seven studies reported no adverse events occurred. Only four studies described how adverse events were assessed [20, [22] [23] [24] . Other outcomes assessed are reported in Table 2 .
Survey of health care professionals
Two hundred and twenty-five (out of 303) health care professionals responded to the survey question about their recommended primary outcome for trials comparing treatments of the frozen shoulder. The most frequently suggested primary outcome was a measure of function and disability (e.g. a validated shoulder score) (132 respondents), followed by pain and range of motion (108 and 104 respondents, respectively). A minority of respondents thought quality of life, period to resolution, patient satisfaction, cost-effectiveness and adverse events should be measured as primary outcomes (see totals in Table 4 ). One hundred and eleven respondents suggested more than one outcome was important. Two hundred and twenty-two respondents stated their health care profession (orthopaedic surgeon, GP with special interest (GPWSI), GP, advanced physiotherapist, physiotherapist). The variability of opinion amongst different health care professional groups was investigated (see Table 4 ). Across the professions, there was little variability in the proportions that suggested pain as a primary outcome. However, function and disability was cited as an important primary outcome measure by a greater proportion of advanced physiotherapists compared with other groups. Around half of the respondents in each professional group cited range of movement as a priority, except advanced physiotherapists (25 %). Quality of life was suggested by a minority of GPs, physiotherapists and advanced physiotherapists surveyed but not orthopaedic surgeons or GPWSIs. Only one respondent (an orthopaedic surgeon) cited adverse events, and of the two respondents who cited cost-effectiveness, one was a GPWSI and other was a physiotherapist. When specified, it was a patientreported measure such as the Oxford Shoulder Score that was preferred to a health care-professional-orientated instrument (13 out of 15 respondents).
Patients' views on outcomes
Searches of three databases (CINAHL, MEDLINE and PsycINFO) identified 1,067 potentially relevant references. Nine full papers were obtained on the basis of screening titles and abstracts; however, none met the inclusion criteria; five papers were clinical studies not containing any qualitative data [25] [26] [27] [28] [29] , two papers focused on non-specific neck/shoulder pain [30, 31] and two papers reported patients' views of Bowen therapy (which was not included in the main review) [32, 33] . All nine papers were re-examined by one of us (SR). One paper [33] contained patients' views relating to outcomes for frozen shoulder (Table 5) . Outcomes reported by patients were pain at night, general pain, reduced mobility (resulting in modification of activities) and the emotional impact of frozen shoulder. The stage of frozen shoulder was not reported, and the methodological quality of this paper was poor.
Discussion
Most of the studies included in this overview measured pain, functional limitation and range of movement, but there was a considerable variation in choice of instrument and less than half of the reviewed studies reported adverse events. Few studies measured health-related quality of life, and no relevant publications were identified that assessed patients' views of their experience of treatments for frozen shoulder. One study provided patients' views on outcomes.
Health care professionals recommended function and disability, pain and range of movement as the primary outcome measures of choice, though around half of those surveyed considered several outcome measures to be equally important. This is the first study to our knowledge that has explored whether a core set of outcomes is needed for studies of primary frozen shoulder using information available from researchers, health care professionals and patients. We (14), passive abduction (12), active internal rotation (12), passive external rotation (11), passive forward flexion (9), passive internal rotation (7), combined movements (hand behind back, hand behind neck, arm stretching towards lower back) (6), passive extension (3), passive adduction (1), total ROM (sum of shoulder motion in 3 planes; internalexternal rotation, flexion-extension, adduction-abduction) (1), cross-body adduction (2), active extension (2),scapular tipping (1), scapulohumeral rhythm (1), arm bending towards the front of the shoulder (1), unspecified active ROM (1), gain in elevation (1) Adverse events (13 studies)
Thirteen studies reported adverse events were assessed; 7 reported no adverse events occurred and four described how adverse events were assessed
Other outcomes (5 studies)
Other outcomes reported: satisfaction with the treatment regimens (1), satisfaction with outcome after hydrodilation or manipulation under anaesthesia (1), rate of improvement (1), efficacy rate (1) and working ability (1) ROM range of movement assessed studies included in a comprehensive, HTA-funded systematic review, but it is possible that other studies exist that may have reported other outcomes. For example, there are several other shoulder-specific function and disability questionnaires identified in the systematic review by Bot et al. [11] that were not used in any of the studies we included. There is therefore a need to be aware of other shoulder-specific questionnaires when developing a core outcome set for use in this patient group. Also, although our searches spanned a considerable time period , there is the possibility that new outcome measures may have come into use since our search end date. The survey of health care professionals' views was limited to choice of primary outcome rather than a core outcome set. Our survey, however, did allow us to identify outcomes considered important across several health care professions. When reviewing patients' views, searches were restricted to only three databases and English-language studies. Within our search limitations, we found one paper that included patients' experiences of frozen shoulder. However, this study had a number of methodological limitations and did not primarily aim to explore outcomes important to patients. Since these searches, one of us (NH) has undertaken a study that specifically explored patients' priorities when living with primary frozen shoulder and their main priority for treatment was improvement in functional outcomes that could be facilitated by relief of pain or stiffness [34] . Themes reported by patients were pain and sleep deprivation resulting from pain, lack of diagnosis or misdiagnosis leading to anxiety and denial, and inconvenience and disability due to inability to use the arm normally [32] . We have not sought further studies systematically since the search end date, so it is possible that additional relevant studies may be available. Another possible data source would be to examine whether the developmental and validation studies of the functional and/or disability measures used in this patient population originally sought patients' views. However, whilst these are shoulder-specific instruments, they are not disease specific and therefore unlikely to focus on frozen shoulder patients to allow for examination of their views [11, 12] . Undertaking a systematic search of such studies is beyond the scope of our study, the purpose of which was to explore the need for a core outcome set rather than provide a definite set of outcomes from which to develop a minimum set of outcomes.
Systematic reviews evaluating effective management pathways for primary frozen shoulder have been limited by methodological issues that preclude data synthesis [2, 3, 7, 35] . Statistical methods are available for combining 16 (57) 20 (71) 7 (25) 2 (7) 0 (0) 0 (0) Hospital Anxiety and Depression Scale (HADS); the treatment by a physiotherapy team including an injection-trained specialist would be better than GP/surgeon outcomes; patient satisfaction
40 (44) 56 (62) 45 (49) 7 (8) 0 (0) 1 (1) Overall outcome at 4 years; patient satisfaction; disturbed sleep different outcome measures that ostensibly measure similar domains, such as the standardised mean difference (SMD) [36] . However, variability in content, scoring methods and reporting styles limits application of these methods of data synthesis. Our findings suggest that, in conjunction with improvements in trial reporting in accordance with CON-SORT guidelines [37] , the use of a core outcome set would facilitate comparison and interpretation of findings across studies and enable data synthesis in systematic reviews. This would enhance the precision of estimated treatment effects and reduce heterogeneity in study findings. An additional benefit would be to reduce selective reporting and thereby limiting the potential for outcome reporting bias that has been found to be a considerably underestimated problem in Cochrane reviews [18] . Appropriate instruments to report these outcomes would need to be selected or developed [38] . In order to reflect outcomes important to patients, a core outcome set should also be developed in partnership with patients with frozen shoulder. In this study, we have identified several outcomes that appear to be meaningful to these patients; however, further exploration of these is required. It is unclear whether any of the currently available outcome measures, including function and disability instruments, accurately reflect the treatment priorities of this patient group. A recent study by Macefield et al. [39] explored and categorised the domains included in patientreported outcome measures in studies of oesophageal cancer, with the further aim of prioritising these domains for inclusion in a core outcome set. This may be an approach that could facilitate the development of a core outcome set for frozen shoulder. Our study did not indicate substantial differences between health care practitioner groups' choice of the primary outcome; nonetheless, there could still be strong differences in opinion between health care professionals that make it difficult to reach a consensus. However, it is important to include all key stakeholders, including patients [40, 41] . The model used by the OMERACT group to develop a core outcome set for rheumatology has shown that this is achievable [42] .
A core outcome set should be developed for frozen shoulder using the methodological approach endorsed by the Core Outcome Measures in Effectiveness Trials (COMET) initiative that is working with the Grading of Recommendations Assessment, Development and Evaluation (GRADE) working group and the Cochrane Collaboration. This group aims to increase the number of core outcome sets developed using evidence-based methods; to increase their impact on the quality of research by raising awareness and increasing their use; and to establish methods for the development of core outcome sets [10] . One of the challenges for developing a core outcome set for frozen shoulder is that the stage of condition is poorly defined, which was reflected in the papers reviewed. As symptoms vary according to the stage of the disease, the choice of outcomes may vary according to different stages of the condition. Consistent use of a standard definition of each stage of frozen shoulder may be a useful first step, and the symptoms associated with each stage should be considered when developing a core outcome set. It may also be important to standardise the time point for the assessment of the primary outcome and to define the time point for the measurement of outcomes in the core set.
Although there is no established ''best'' practice to develop core outcome sets, Sinha et al. [43] recently conducted a systematic review of studies that have used the Delphi techniques to elicit outcomes of importance. This review advised that patients and clinicians should be involved in the Delphi process and suggests that differences in opinion should be explored [43] . Participants should also be able to suggest potential outcomes without being influenced by facilitators, steering committees or reviews of the literature and attrition should be minimised, particularly as people with minority opinions may be more likely to drop out of studies that use the Delphi process [43] . Particular outcomes may be associated with specific treatments or treatment pathways and the wide range of interventions and combinations of interventions available for frozen shoulder should be taken into consideration when developing a core outcome set. The involvement of a variety of health professionals and patients on the various treatment pathways is also necessary. This could yield a large number of outcomes; therefore, effective consensus methods are needed. A study by Williamson et al. [10] emphasizes the use of appropriate consensus methods to identify core outcomes, review, feedback and update outcome sets and highlights the importance of transparent reporting of the methods used to develop the core outcome set and registration with COMET. Additionally, a core outcome set must be applicable and be adopted internationally and across disciplines in order to be able to compare all research in this area. International consensus has previously been achieved using expert panels and conference workshops [13, 44] .
The development of a core outcome set would be of benefit to patients, policy makers, researchers and practitioners in frozen shoulder. This would improve the design and reporting of studies and availability of data for evidence synthesis. Robust evidence-based methods that reflect the views of all stakeholders should be used to develop a core outcome set.
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